444 related articles for article (PubMed ID: 16450332)
1. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
Mulder WJ; Strijkers GJ; van Tilborg GA; Griffioen AW; Nicolay K
NMR Biomed; 2006 Feb; 19(1):142-64. PubMed ID: 16450332
[TBL] [Abstract][Full Text] [Related]
2. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
3. Targeted contrast agents for magnetic resonance imaging and ultrasound.
Morawski AM; Lanza GA; Wickline SA
Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
[TBL] [Abstract][Full Text] [Related]
4. Contrast agents: magnetic resonance.
Burtea C; Laurent S; Vander Elst L; Muller RN
Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
[TBL] [Abstract][Full Text] [Related]
5. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes.
Erdogan S; Torchilin VP
Methods Mol Biol; 2010; 605():321-34. PubMed ID: 20072891
[TBL] [Abstract][Full Text] [Related]
7. Iron oxide MR contrast agents for molecular and cellular imaging.
Bulte JW; Kraitchman DL
NMR Biomed; 2004 Nov; 17(7):484-99. PubMed ID: 15526347
[TBL] [Abstract][Full Text] [Related]
8. A novel cholic acid-based contrast enhancement agent for targeted MRI.
Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
[TBL] [Abstract][Full Text] [Related]
9. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies.
Deddens LH; Van Tilborg GA; Mulder WJ; De Vries HE; Dijkhuizen RM
Cerebrovasc Dis; 2012; 33(4):392-402. PubMed ID: 22456323
[TBL] [Abstract][Full Text] [Related]
10. A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging.
Hak S; Sanders HM; Agrawal P; Langereis S; Grüll H; Keizer HM; Arena F; Terreno E; Strijkers GJ; Nicolay K
Eur J Pharm Biopharm; 2009 Jun; 72(2):397-404. PubMed ID: 18940253
[TBL] [Abstract][Full Text] [Related]
11. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
[TBL] [Abstract][Full Text] [Related]
12. Use of lanthanide-grafted inorganic nanoparticles as effective contrast agents for cellular uptake imaging.
Voisin P; Ribot EJ; Miraux S; Bouzier-Sore AK; Lahitte JF; Bouchaud V; Mornet S; Thiaudière E; Franconi JM; Raison L; Labrugère C; Delville MH
Bioconjug Chem; 2007; 18(4):1053-63. PubMed ID: 17511491
[TBL] [Abstract][Full Text] [Related]
13. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging.
Lu J; Ma S; Sun J; Xia C; Liu C; Wang Z; Zhao X; Gao F; Gong Q; Song B; Shuai X; Ai H; Gu Z
Biomaterials; 2009 May; 30(15):2919-28. PubMed ID: 19230966
[TBL] [Abstract][Full Text] [Related]
14. Target-specific paramagnetic and superparamagnetic micelles for molecular MR imaging.
Straathof R; Strijkers GJ; Nicolay K
Methods Mol Biol; 2011; 771():691-715. PubMed ID: 21874503
[TBL] [Abstract][Full Text] [Related]
15. A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI.
Kamaly N; Kalber T; Kenny G; Bell J; Jorgensen M; Miller A
Org Biomol Chem; 2010 Jan; 8(1):201-11. PubMed ID: 20024151
[TBL] [Abstract][Full Text] [Related]
16. Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents.
Shieh DB; Cheng FY; Su CH; Yeh CS; Wu MT; Wu YN; Tsai CY; Wu CL; Chen DH; Chou CH
Biomaterials; 2005 Dec; 26(34):7183-91. PubMed ID: 15964622
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles for bioimaging.
Sharma P; Brown S; Walter G; Santra S; Moudgil B
Adv Colloid Interface Sci; 2006 Nov; 123-126():471-85. PubMed ID: 16890182
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
[TBL] [Abstract][Full Text] [Related]
19. A universal scaling law to predict the efficiency of magnetic nanoparticles as MRI T(2)-contrast agents.
Vuong QL; Berret JF; Fresnais J; Gossuin Y; Sandre O
Adv Healthc Mater; 2012 Jul; 1(4):502-12. PubMed ID: 23184784
[TBL] [Abstract][Full Text] [Related]
20. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
